The Acute Treatment of Migraine Attack in Adults and American Headache Society Evidence Assessment of Migraine Pharmacotherapies

Simple item page
dc.contributor.authorDikmen, Pinar Yalinay
dc.date.accessioned2023-02-21T12:32:28Z
dc.date.available2023-02-21T12:32:28Z
dc.date.issued2016-01-01
dc.description.abstractMigraine is a common, the primary debilitating and recurring headache disorder. The main purpose migraine acute pharmacology is to reduce the impact and disability caused by the attack of migraine. This review primarily reminds clinical pearls in acute treatment of migraine and also summarizes the American Headache Society Evidence Assessment of Migraine Pharmacotherapies that published last year.
dc.description.issue1
dc.description.pages3-7
dc.description.volume22
dc.identifier.doi10.4274/tnd.93753
dc.identifier.urihttps://hdl.handle.net/11443/1099
dc.identifier.urihttp://dx.doi.org/10.4274/tnd.93753
dc.identifier.wosWOS:000377538300002
dc.publisherTURKISH NEUROLOGICAL SOC
dc.relation.ispartofTURKISH JOURNAL OF NEUROLOGY
dc.subjectMigraine
dc.subjectattack treatment
dc.subjectmigraine pharmacotherapies
dc.titleThe Acute Treatment of Migraine Attack in Adults and American Headache Society Evidence Assessment of Migraine Pharmacotherapies
dc.typeArticle

Files

Collections

WOS